Amphastar Pharmaceuticals, Inc. ( AMPH) - Key Metrics
AMPH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $4.21 | $0.70 | $1.18 | $0.98 |
| 2026Q1 | $3.78 | $0.14 | $1.06 | $0.85 |
| 2025Q4 | $3.99 | $0.53 | $0.72 | $0.54 |
| 2025Q3 | $4.13 | $0.37 | $1.13 | $1.02 |
| 2025Q2 | $3.71 | $0.66 | $0.76 | $0.53 |
AMPH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 7.31 |
| 2026Q1 | 0% | 34.98 |
| 2025Q4 | 0% | 12.63 |
| 2025Q3 | 0% | 17.53 |
| 2025Q2 | 0% | 8.70 |
AMPH Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 4.85% | 0% |
| 2026Q1 | 4.32% | 0% |
| 2025Q4 | 2.00% | 0% |
| 2025Q3 | 3.81% | 0% |
| 2025Q2 | 2.32% | 0% |
AMPH
Price: $27.39
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.65 USD
P/E Ratio: 12.11
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 105125
Ebitda: 2.1 millionMarket Capitalization: 1.0 billion